Subscribe Now
You are here : Home / Quarterly Results / AUROBINDO PHARMA LTD

AUROBINDO PHARMA Quarterly Results Analysis Q2FY22 [Sep2021]

Q-o-Q REVENUES OPERATING PROFIT PROFIT AFTER TAX EPS Updated : 09-Nov-21 Details👇

AUROBINDO PHARMA Quarterly Results

Consolidated Sep2021
UnAudited
Jun2021
UnAudited
Mar2021
Audited
Dec2020
UnAudited
Sep2020
UnAudited
Jun2020
UnAudited
Mar2020
Audited
Dec2019
UnAudited
Revenues ₹5,942 Cr ₹5,702 Cr ₹6,002 Cr ₹6,365 Cr ₹6,483 Cr ₹5,925 Cr ₹6,158 Cr ₹5,895 Cr
Expenses ₹4,755 Cr ₹4,493 Cr ₹4,727 Cr ₹4,996 Cr ₹5,051 Cr ₹4,667 Cr ₹4,842 Cr ₹4,687 Cr
Operating Income ₹1,187 Cr ₹1,209 Cr ₹1,275 Cr ₹1,369 Cr ₹1,433 Cr ₹1,257 Cr ₹1,316 Cr ₹1,208 Cr
Other Income ₹97 Cr ₹110 Cr ₹78 Cr ₹133 Cr ₹54 Cr ₹116 Cr ₹33 Cr ₹31 Cr
Interest ₹10 Cr ₹13 Cr ₹18 Cr ₹19 Cr ₹16 Cr ₹21 Cr ₹32 Cr ₹37 Cr
Depreciation ₹294 Cr ₹280 Cr ₹266 Cr ₹277 Cr ₹257 Cr ₹256 Cr ₹232 Cr ₹250 Cr
Profit Before Tax ₹979 Cr ₹1,027 Cr ₹1,069 Cr ₹4,020 Cr ₹1,214 Cr ₹1,096 Cr ₹1,097 Cr ₹939 Cr
Profit After Tax ₹708 Cr ₹779 Cr ₹810 Cr ₹2,961 Cr ₹828 Cr ₹795 Cr ₹882 Cr ₹706 Cr
EPS ₹11.90 ₹13.14 ₹13.68 ₹50.29 ₹13.79 ₹13.37 ₹14.75 ₹12.04

Check out Industry Peers

Peers & Returns1W1M1Y
AUROBINDO PHARMA -8% -15% -34.4%
SUN PHARMACEUTICAL INDUSTRIES -3.7% 1.6% 34.6%
DIVIS LABORATORIES -9.6% -9.5% 13.5%
DR REDDYS LABORATORIES -6% -6.9% -13.7%
CIPLA 1% -2.7% 7.1%
GLAND PHARMA -7.8% -12.6% 45.3%
PIRAMAL ENTERPRISES -8.2% -9.4% 48.2%
CADILA HEALTHCARE -6.7% -13.8% -18.4%
TORRENT PHARMACEUTICALS -1.2% 0.4% 14%

AUROBINDO PHARMA Quarterly Revenues

Revenues
Q-o-Q

4.21 %

Y-o-Y

-8.35 %

Quarters Revenues % Change
Sep2021 ₹5,942 Cr
4.21
Jun2021 ₹5,702 Cr
-4.99
Mar2021 ₹6,002 Cr
-5.71
Dec2020 ₹6,365 Cr
-1.83
Sep2020 ₹6,483 Cr
9.43
Jun2020 ₹5,925 Cr
-3.79
Mar2020 ₹6,158 Cr
4.47
Dec2019 ₹5,895 Cr -

AUROBINDO PHARMA Quarterly Operating Profit

Operating Profit
Q-o-Q

-1.87 %

Y-o-Y

-17.18 %

Quarters Operating Profit % Change
Sep2021 ₹1,187 Cr
-1.87
Jun2021 ₹1,209 Cr
-5.12
Mar2021 ₹1,275 Cr
-6.86
Dec2020 ₹1,369 Cr
-4.48
Sep2020 ₹1,433 Cr
13.95
Jun2020 ₹1,257 Cr
-4.47
Mar2020 ₹1,316 Cr
8.96
Dec2019 ₹1,208 Cr -
Operating Margins
Q-o-Q

-5.85 %

Y-o-Y

-9.64 %

Quarters Operating Margin% % Change
Sep2021 19.97%
-5.85
Jun2021 21.21%
-0.14
Mar2021 21.24%
-1.21
Dec2020 21.5%
-2.71
Sep2020 22.1%
4.15
Jun2020 21.22%
-0.70
Mar2020 21.37%
4.29
Dec2019 20.49% -

AUROBINDO PHARMA Quarterly Profit After Tax

Profit After Tax(PAT)
Q-o-Q

-9.14 %

Y-o-Y

-14.50 %

Quarters Profit After Tax % Change
Sep2021 ₹708 Cr
-9.14
Jun2021 ₹779 Cr
-3.78
Mar2021 ₹810 Cr
-72.66
Dec2020 ₹2,961 Cr
257.68
Sep2020 ₹828 Cr
4.10
Jun2020 ₹795 Cr
-9.89
Mar2020 ₹882 Cr
25.00
Dec2019 ₹706 Cr -
PAT Margins
Q-o-Q

-12.81 %

Y-o-Y

-6.73 %

Quarters PAT Margin(%) % Change
Sep2021 11.91 %
-12.81
Jun2021 13.66 %
1.26
Mar2021 13.49 %
-71.00
Dec2020 46.52 %
264.29
Sep2020 12.77 %
-4.84
Jun2020 13.42 %
-6.35
Mar2020 14.33 %
19.62
Dec2019 11.98 % -

AUROBINDO PHARMA Quarterly Earnings Per Share (EPS)

EPS
Q-o-Q

-9.44 %

Y-o-Y

-13.71 %

Quarters EPS % Change
Sep2021 ₹11.9
-9.44
Jun2021 ₹13.14
-3.95
Mar2021 ₹13.68
-72.80
Dec2020 ₹50.29
264.68
Sep2020 ₹13.79
3.14
Jun2020 ₹13.37
-9.36
Mar2020 ₹14.75
22.51
Dec2019 ₹12.04 -
STOCK RESEARCH & ANALYSIS Smart-Investing
LEARN VIA VIDEO COURSE Stock Market Investing Simplified- The best Video Course by Smart-Investing.in

AUROBINDO PHARMA related INDICES

BSE Indices1W1M1Y
S&P BSE DIVIDEND STABILITY -2% 5.4% 20%
S&P BSE ENHANCED VALUE -2.4% 6.7% 42.4%
S&P BSE CARBONEX -4.4% 1.7% 19.5%
S&P BSE LARGECAP -4.5% 1.6% 19.6%
S&P BSE 100 LARGECAP TMC -4.6% 1.3% 19.7%
S&P BSE 100 -4.6% 1.5% 19.6%
S&P BSE LARGE MIDCAP -4.6% 1.3% 20.8%
S&P BSE HEALTHCARE -4.6% -3.5% 9.9%
S&P BSE 200 -4.7% 1.2% 21.5%
S&P BSE SENSEX NEXT 50 -4.7% 1.2% 21.9%
S&P BSE 250 LARGEMIDCAP -4.7% 1.1% 22.1%
S&P BSE 500 -4.7% 1.2% 23.7%
S&P BSE ALLCAP -4.8% 1.4% 25%
NSE Indices1W1M1Y
NIFTY 100 EQUAL WEIGHT -3.9% 1% 24.2%
NIFTY PHARMA -4.4% -3% 1.8%
NIFTY HEALTHCARE -4.5% -3.7% NA
NIFTY NEXT 50 -4.6% -1.2% 21.6%
NIFTY 100 -4.6% 1.3% 19.5%
NSE QUALITY 30 -4.6% -1.6% 12%
NIFTY 200 -4.7% 1.1% 21.4%
NIFTY 500 -4.8% 1.1% 23.8%
NIFTY LARGE MIDCAP 250 -4.9% 0.6% 27.5%
NIFTY500 MULTICAP 50:25:25 -5% 1.3% 31.8%

You may also like the below Video Courses

Check out Intrinsic Value of Industry Peers
Intrinsic Value of SUN PHARMACEUTICAL INDUSTRIES LTD
Intrinsic Value of DIVIS LABORATORIES LTD
Intrinsic Value of DR REDDYS LABORATORIES LTD
Intrinsic Value of CIPLA LTD
Intrinsic Value of GLAND PHARMA LTD
Intrinsic Value of PIRAMAL ENTERPRISES LTD
Intrinsic Value of CADILA HEALTHCARE LTD
Intrinsic Value of TORRENT PHARMACEUTICALS LTD
Intrinsic Value of ALKEM LABORATORIES LTD
Intrinsic Value of LUPIN LTD
Intrinsic Value of AUROBINDO PHARMA LTD
Intrinsic Value of BIOCON LTD
Intrinsic Value of ABBOTT INDIA LTD
Intrinsic Value of LAURUS LABS LTD
Intrinsic Value of IPCA LABORATORIES LTD
Check out Annual Financials of Industry Peers
Share Price & Financials of SUN PHARMACEUTICAL INDUSTRIES LTD | BOM: 524715 | NSE: SUNPHARMA
Share Price & Financials of DIVIS LABORATORIES LTD | BOM: 532488 | NSE: DIVISLAB
Share Price & Financials of DR REDDYS LABORATORIES LTD | BOM: 500124 | NSE: DRREDDY
Share Price & Financials of CIPLA LTD | BOM: 500087 | NSE: CIPLA
Share Price & Financials of GLAND PHARMA LTD | BOM: 543245 | NSE: GLAND
Share Price & Financials of PIRAMAL ENTERPRISES LTD | BOM: 500302 | NSE: PEL
Share Price & Financials of CADILA HEALTHCARE LTD | BOM: 532321 | NSE: CADILAHC
Share Price & Financials of TORRENT PHARMACEUTICALS LTD | BOM: 500420 | NSE: TORNTPHARM
Share Price & Financials of ALKEM LABORATORIES LTD | BOM: 539523 | NSE: ALKEM
Share Price & Financials of LUPIN LTD | BOM: 500257 | NSE: LUPIN
Share Price & Financials of AUROBINDO PHARMA LTD | BOM: 524804 | NSE: AUROPHARMA
Share Price & Financials of BIOCON LTD | BOM: 532523 | NSE: BIOCON
Share Price & Financials of ABBOTT INDIA LTD | BOM: 500488 | NSE: ABBOTINDIA
Share Price & Financials of LAURUS LABS LTD | BOM: 540222 | NSE: LAURUSLABS
Share Price & Financials of IPCA LABORATORIES LTD | BOM: 524494 | NSE: IPCALAB

Compare Analytics
SUN PHARMACEUTICAL INDUSTRIES LTD vs DIVIS LABORATORIES LTD vs DR REDDYS LABORATORIES LTD
CIPLA LTD vs GLAND PHARMA LTD vs PIRAMAL ENTERPRISES LTD
CADILA HEALTHCARE LTD vs TORRENT PHARMACEUTICALS LTD vs ALKEM LABORATORIES LTD
LUPIN LTD vs AUROBINDO PHARMA LTD vs BIOCON LTD
ABBOTT INDIA LTD vs LAURUS LABS LTD vs IPCA LABORATORIES LTD
Browse Market Cap of Industry Peers
Market Cap of SUN PHARMACEUTICAL INDUSTRIES LTD
Market Cap of DIVIS LABORATORIES LTD
Market Cap of DR REDDYS LABORATORIES LTD
Market Cap of CIPLA LTD
Market Cap of GLAND PHARMA LTD
Market Cap of PIRAMAL ENTERPRISES LTD
Market Cap of CADILA HEALTHCARE LTD
Market Cap of TORRENT PHARMACEUTICALS LTD
Market Cap of ALKEM LABORATORIES LTD
Market Cap of LUPIN LTD
Market Cap of AUROBINDO PHARMA LTD
Market Cap of BIOCON LTD
Market Cap of ABBOTT INDIA LTD
Market Cap of LAURUS LABS LTD
Market Cap of IPCA LABORATORIES LTD

Disclosure

SEBI Research Analyst
The Founder of this website, Mr. Rohit Katiyar is registered with SEBI as a Research Analyst [INH000007377].


All Stocks : A - Z

ALL   A  B  C  D  E  F  G  H  I  J  K  L  M  N  O  P  Q  R  S  T  U  V  W  X  Y  Z